STRATA Skin Sciences (SSKN) Net Income towards Common Stockholders Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.52% |
| Mar 31, 2025 | -15.82% |
| Dec 31, 2024 | -55.60% |
| Sep 30, 2024 | -19.81% |
| Jun 30, 2024 | 1.05% |
| Mar 31, 2024 | -22.58% |
| Dec 31, 2023 | -98.85% |
| Sep 30, 2023 | -14.33% |
| Jun 30, 2023 | -18.51% |
| Mar 31, 2023 | -40.82% |
| Dec 31, 2022 | -15.05% |
| Sep 30, 2022 | 38.70% |
| Jun 30, 2022 | -22.60% |
| Mar 31, 2022 | 8.84% |
| Dec 31, 2021 | 0.87% |
| Sep 30, 2021 | 19.16% |
| Jun 30, 2021 | 16.79% |
| Mar 31, 2021 | 6.71% |
| Dec 31, 2020 | 53.87% |
| Mar 31, 2020 | 29.76% |
| Dec 31, 2019 | 39.50% |
| Sep 30, 2019 | 18.16% |
| Jun 30, 2019 | 25.05% |
| Mar 31, 2019 | 23.80% |
| Dec 31, 2018 | 50.97% |
| Sep 30, 2018 | 39.09% |
| Jun 30, 2018 | 33.42% |
| Mar 31, 2018 | 39.90% |
| Dec 31, 2017 | 26.83% |
| Sep 30, 2017 | -16.47% |
| Jun 30, 2017 | 19.61% |
| Mar 31, 2017 | 7.15% |
| Dec 31, 2016 | 27.82% |
| Sep 30, 2016 | 24.42% |
| Jun 30, 2016 | 16.03% |
| Mar 31, 2016 | 7.11% |
| Dec 31, 2015 | 36.15% |
| Sep 30, 2015 | -19.71% |
| Jun 30, 2015 | -16.44% |